From Casetext: Smarter Legal Research

Therasense, Inc. v. Becton, Dickinson & Co.

United States Court of Appeals for the Federal Circuit
Oct 23, 2012
2012-1504 (Fed. Cir. Oct. 23, 2012)

Opinion

2012-1504 2012-1365 2012-1503

10-23-2012

THERASENSE, INC. (NOW KNOWN AS ABBOTT DIABETES CARE, INC.) AND ABBOTT LABORATORIES, Plaintiffs-Appellees, v. BECTON, DICKINSON AND COMPANY AND NOVA BIOMEDICAL CORPORATION, Defendants-Appellants, AND BAYER HEALTHCARE LLC, Defendant.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the Northern District of California in consolidated case nos. 04-CV-2123, 04-CV-3327, 04-CV-3732, and 05-CV-3117, Judge William H. Alsup.

Appeals from the United States District Court for the Northern District of California in consolidated case nos. 04-CV-2123, 04-CV-3327, 04-CV-3732, and 05-CV-3117, Judge William H. Alsup.

ON MOTION


ORDER

Upon consideration of Therasense, Inc. and Abbott Laboratories's unopposed motion to withdraw appeals 2012-1365 and 2012-1503,

IT IS ORDERED THAT:

(1) The motion is granted. The appeals are dismissed.

(2) Each side shall bear its own costs in 2012-1365 and 2012-1503.

(3) The revised official caption in 2012-1504 is reflected above. Becton's principal brief in 2012-1504 is due within 30 days of the date of filing of this order.

FOR THE COURT

_________________

Jan Horbaly

Clerk
s25 Issued As A Mandate (For 2012-1365 and 2012-1503 Only): OCT 23 2012


Summaries of

Therasense, Inc. v. Becton, Dickinson & Co.

United States Court of Appeals for the Federal Circuit
Oct 23, 2012
2012-1504 (Fed. Cir. Oct. 23, 2012)
Case details for

Therasense, Inc. v. Becton, Dickinson & Co.

Case Details

Full title:THERASENSE, INC. (NOW KNOWN AS ABBOTT DIABETES CARE, INC.) AND ABBOTT…

Court:United States Court of Appeals for the Federal Circuit

Date published: Oct 23, 2012

Citations

2012-1504 (Fed. Cir. Oct. 23, 2012)